Key result
Preoperative 10-gene leukocyte model predicts mortality risk following MCS implantation in HF patients.
Why the study?
Can whole-genome mRNA expression in circulating leukocytes predict adverse outcomes and survival in heart failure patients undergoing mechanical circulatory support?
Cohort (n=22)
Can whole-genome mRNA expression in circulating leukocytes predict adverse outcomes and survival in heart failure patients undergoing mechanical circulatory support?
A 10-gene leukocyte expression model derived from preoperative samples may predict mortality risk and provide mechanistic insights into the systemic inflammatory response following mechanical circulatory support implantation.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for preoperative risk stratification in MCS; leaves open whether the model improves outcomes or warrants prospective validation.
Background The implantation of mechanical circulatory support (MCS) devices in heart failure patients is associated with a systemic inflammatory response, potentially leading to death from multiple organ dysfunction syndrome. Previous studies point to the involvement of many mechanisms, but an integrative hypothesis does not yet exist. Using time-dependent whole-genome mRNA expression in circulating leukocytes, we constructed a systems-model to improve mechanistic understanding and prediction of adverse outcomes. Methods We sampled peripheral blood mononuclear cells from 22 consecutive patients undergoing MCS surgery, at 5 timepoints: day -1 preoperative, and days 1, 3, 5, and 8 postoperative. Phenotyping was performed using 12 clinical parameters, 2 organ dysfunction scoring systems, and survival outcomes. We constructed a systems-representation using weighted gene co-expression network analysis, and annotated eigengenes using gene ontology, pathway, and transcription factor binding site enrichment analyses. Genes and eigengenes were mapped to the clinical phenotype using a linear mixed-effect model, with Cox models also fit at each timepoint to survival outcomes. Finally, we selected top genes associated with survival across all timepoints, and trained a penalized Cox model, based on day -1 data, to predict mortality risk thereafter. Results We inferred a 19-module network, in which most module eigengenes correlated with at least one aspect of the clinical phenotype. We observed a response to surgery orchestrated into stages: first, activation of the innate immune response, followed by anti-inflammation, and finally reparative processes such as mitosis, coagulation, and apoptosis. Eigengenes related to red blood cell production and extracellular matrix degradation became predictors of survival late in the timecourse, consistent with organ failure due to disseminated coagulopathy. Our final predictive model consisted of 10 genes: IL2RA , HSPA7, AFAP1, SYNJ2, LOC653406, GAPDHP35, MGC12916, ZRSR2 , and two currently unidentified genes, warranting further investigation. Conclusion Our model provides an integrative representation of leukocyte biology during the systemic inflammatory response following MCS device implantation. It demonstrates consistency with previous hypotheses, identifying a number of known mechanisms. At the same time, it suggests novel hypotheses about time-specific targets.
No takes yet. Share an insight, caveat, or question.
Wisniewski et al. (2015) conducted a cohort in Heart failure requiring mechanical circulatory support (n=22). Mechanical circulatory support (MCS) surgery was evaluated on Survival outcomes and mortality risk. A 10-gene predictive model based on preoperative leukocyte mRNA expression was developed to predict mortality risk following mechanical circulatory support device implantation in heart failure patients.
Synapse has enriched 10 related papers. Consider them for comparative context: